Doing the Deal: Post-Brexit Investment Implications
With the no-deal risk factor now removed, investors can now weigh the investment implications for various UK exposures.
We believe the current conditions may support investment grade credit, although financials will be under pressure given the lack of equivalence with the EU. Broader UK equities may now represent a value opportunity.
The UK and EU finally managed to agree on a trade deal. As had become habitual in this game of brinkmanship, the agreement came close to the deadline, meaning there was a mad rush to ratify it before the end of the year.
The ability to negotiate a deal was one of the key risk factors for the final quarter of 2020, so the fact that it has been resolved should be viewed as a positive for risk assets. That said, the fairly muted reaction from the GBP – the broad trade-weighted index initially bounced but has failed to break to new highs – suggests that the market was broadly positioned for a deal.
UK equity markets are higher but, globally, equity performance has also been driven by the signing into law of the US stimulus package, making it hard to determine a specific Brexit effect. This muted market reaction may be in part due to the time of the year, with trading possibly limited to market participants neutralising existing positions rather than initiating fresh ones, but it may also be that its financial impact is unclear.
An opportunity in investment grade credit
A deal is better than no deal, but there are some material costs that exporting businesses will now be forced to bear in the form of proving compliance with EU regulations. Perhaps the biggest issue with the deal is the lack of any clarity around access for financial services providers to the EU single market. Equivalence has not been granted – which is odd from a practical standpoint given the UK is currently fully aligned – but will be looked at by March 2021. Most of the large banks and asset managers should have made provisions to run operations out of the EU, limiting the disruption, but it is still likely to add to costs and this may ultimately prove prohibitive for smaller financial companies.
From that perspective, while the deal and the rising tide of equities should support investment grade credit, limiting exposure to financials may be wise. In this context, an all maturity index such as the Bloomberg Barclays Sterling Corporate Bond Index, where financials constitute around a third of the index, is better positioned than shorter options such as the Bloomberg Barclays 0-5 Year Sterling Corporate Bond Index, which is closer to 50%. There will be some risks around this, given its longer duration (8.7 years versus 2.5 years) although the longer index provides compensation in the form of a higher running yield (an additional 55bp) and a more attractive spread to gilts (+25bp).
Gilts carry on regardless
In the government bond space, gilts have not moved very far. Again, this could be indicative of positioning at this time of year or the fact that a deal was already largely in the price. Overall, it is hard to view recent developments as positive for gilts for a few reasons:
A no-trade-deal scenario has been averted, greatly reducing the need for safe haven assets. A no-deal scenario would also probably have forced the Bank of England (BoE) to cut rates and speed up gilt purchases.
The Oxford University/AstraZeneca vaccine has been authorised. This news should allow an accelerated immunisation programme in the UK.
Even though a post-Christmas/New Year surge in infections looks likely, markets have so far shown their ability to look through near-term issues and focus on the better economic backdrop that may persist for most of 2021. The State Street Global Advisors forecast for UK growth is an impressive 7.9% for 2021. While this may prove a little over-optimistic given the lockdown now in place, it appears unlikely that the BoE will cut rates into negative territory with growth running at its fastest pace since the 1980s. Yet the money markets continue to price an eventual cut (the SONIA forwards price around a 50% probability of a 25bp cut by end Q1 2022). The market is likely to gradually price out the probability of a cut, which creates a bearish backdrop for gilts.
Bank of England Rate Cuts Still Priced by the SONIA Forwards
To some degree yields may be held down by the BoE’s ongoing programme of purchases. The MPC agreed a further £150 billion of gilt purchases at the November meeting but this has been insufficient to stem the rise in yields with the 2-30Y curve slope around 35bp steeper than it was in May.
So for gilt investors, limiting duration risk looks appropriate. To put it in context, the yield to worst on the Bloomberg Barclays UK Gilt 1-5 Index is -10bp while on the Bloomberg Barclays Sterling Gilt Index it is 35bp. This 45bp yield differential would appear to favour the all gilts index but there is a substantial difference in duration with the shorter index at 2.9 years while the longer one is 13.3 years. This difference in the price sensitivity of the index to moves in yields suggests that a yield shift in the curve of as little as 5bp would wipe out the carry advantages from the longer index.
UK equities interesting during rotation to value
Institutional investors are heavily underweight in UK equities, with this being the most unloved developed market since the Brexit referendum in 2016. Take away the uncertainty and potential disruption, as the Brexit deal has done, and the region looks interesting as a value and recovery play.
Compared with other developed markets (i.e. the MSCI World Index), UK equities (i.e. the FTSE All-Share Index) appear cheap on common measures of earnings, EBITDA and book value; for example, the prospective P/E for UK equities is 15.1x versus 20.8x for MSCI World, a discount of more than 25%.
Over the last few years, an important source of income for the UK economy, namely oil and gas companies operating in the North Sea and worldwide, has suffered from low oil prices. This damage may now be assuaged, with mobility expected to improve as COVID-19 vaccines are rolled out.
Nevertheless, much larger weights in the UK stock market are now found in consumer staples (including leading global food and beverage brands) and financials (operations for banks and financial services companies will need to evolve, as mentioned above, but the shares seem extremely cheap and financial conditions are sound).
In terms of accessing the market, the FTSE All-Share offers comprehensive, diversified exposure across UK businesses, earning just over 50% of their revenue overseas, according to FTSE Russell. This index of small, mid and large cap companies outperformed FTSE 100 last year and consistently over the long term (since the inception of FTSE 100 in 1984, FTSE All-Share has outperformed by 0.8% p.a.). Given the smaller size component, this relative outperformance could continue following long-term trends and has less reliance on the direction of sterling for exporters than the FTSE 100 index.
For professional investor use only.
France: State Street Global Advisors Ireland Limited, Paris branch is a branch of State Street Global Advisors Ireland Limited, registered in Ireland with company number 145221, authorised and regulated by the Central Bank of Ireland, and whose registered office is at 78 Sir John Rogerson’s Quay, Dublin 2. State Street Global Advisors Ireland Limited, Paris Branch, is registered in France with company number RCS Nanterre 832 734 602 and whose office is at Immeuble Défense Plaza, 23-25 rue Delarivière-Lefoullon, 92064 Paris La Défense Cedex, France. T: (+33) 1 44 45 40 00. F: (+33) 1 44 45 41 92. Germany: State Street Global Advisors GmbH, Brienner Strasse 59, D-80333 Munich. Authorised and regulated by the Bundesanstalt für Finanzdienstleistungsaufsicht (“BaFin”). Registered with the Register of Commerce Munich HRB 121381. T: +49 (0)89-55878-400. F: +49 (0)89-55878-440. Israel: No action has been taken or will be taken in Israel that would permit a public offering of the Securities or distribution of this sales brochure to the public in Israel. This sales brochure has not been approved by the Israel Securities Authority (the ‘ISA’). Accordingly, the Securities shall only be sold in Israel to an investor of the type listed in the First Schedule to the Israeli Securities Law, 1978, which has confirmed in writing that it falls within one of the categories listed therein (accompanied by external confirmation where this is required under ISA guidelines), that it is aware of the implications of being considered such an investor and consents thereto, and further that the Securities are being purchased for its own account and not for the purpose of re-sale or distribution. This sales brochure may not be reproduced or used for any other purpose, nor be furnished to any other person other than those to whom copies have been sent. Nothing in this sales brochure should be considered investment advice or investment marketing as defined in the Regulation of Investment Advice, Investment Marketing and Portfolio Management Law, 1995 (“the Investment Advice Law”). Investors are encouraged to seek competent investment advice from a locally licensed investment advisor prior to making any investment. State Street is not licensed under the Investment Advice Law, nor does it carry the insurance as required of a licensee thereunder. This sales brochure does not constitute an offer to sell or solicitation of an offer to buy any securities other than the Securities offered hereby, nor does it constitute an offer to sell to or solicitation of an offer to buy from any person or persons in any state or other jurisdiction in which such offer or solicitation would be unlawful, or in which the person making such offer or solicitation is not qualified to do so, or to a person or persons to whom it is unlawful to make such offer or solicitation. Investing involves risk including the risk of loss of principal. The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without SSGA’s express written consent. The trademarks and service marks referenced herein are the property of their respective owners. Third party data providers make no warranties or representations of any kind relating to the accuracy, completeness or timeliness of the data and have no liability for damages of any kind relating to the use of such data. Ireland: State Street Global Advisors Ireland Limited is regulated by the Central Bank of Ireland. Registered office address 78 Sir John Rogerson’s Quay, Dublin 2. Registered Number: 145221. T: +353 (0)1 776 3000. F: +353 (0)1 776 3300. Italy: State Street Global Advisors Ireland Limited, Milan Branch (Sede Secondaria di Milano) is a branch of State Street Global Advisors Ireland Limited, registered in Ireland with company number 145221, authorised and regulated by the Central Bank of Ireland, and whose registered office is at 78 Sir John Rogerson’s Quay, Dublin 2. State Street Global Advisors Ireland Limited, Milan Branch (Sede Secondaria di Milano), is registered in Italy with company number 10495250960 - R.E.A. 2535585 and VAT number 10495250960 and whose office is at Via Ferrante Aporti, 10 - 20125 Milano, Italy. Telephone: +39 02 32066 100. Facsimile: +39 02 32066 155. Netherlands: State Street Global Advisors Netherlands, Apollo Building, 7th floor Herikerbergweg 29 1101 CN Amsterdam, Netherlands. Telephone: 31 20 7181701. SSGA Netherlands is a branch office of State Street Global Advisors Ireland Limited, registered in Ireland with company number 145221, authorised and regulated by the Central Bank of Ireland, and whose registered office is at 78 Sir John Rogerson’s Quay, Dublin 2. Switzerland: State Street Global Advisors AG, Beethovenstr. 19, CH-8027 Zurich. Authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-105.078.458. T: +41 (0)44 245 70 00. F: +41 (0)44 245 70 16. United Kingdom: State Street Global Advisors Limited. Authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 2509928. VAT No. 5776591 81. Registered office: 20 Churchill Place, Canary Wharf, London, E14 5HJ. T: 020 3395 6000. F: 020 3395 6350.
Standard & Poor’s, S&P and SPDR are registered trademarks of Standard & Poor’s Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation’s financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index. All forms of investments carry risks, including the risk of losing all of the invested amount. Such activities may not be suitable for everyone.The information provided does not constitute investment advice and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell a security. It does not take into account any investor’s particular investment objectives, strategies, tax status or investment horizon. You should consult your tax and financial advisor. This document contains certain statements that may be deemed forward looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. Issuing Office: This document has been issued by State Street Global Advisors Ireland (“SSGA”), regulated by the Central Bank of Ireland. Registered office address 78 Sir John Rogerson’s Quay, Dublin 2. Registerednumber 145221. T: +353 (0)1 776 3000. Fax: +353 (0)1 776 3300. Web: ssga.com.
ETFs trade like stocks, are subject to investment risk and will fluctuate in market value. The investment return and principal value of an investment will fluctuate in value, so that when shares are sold or redeemed, they may be worth more or less than when they were purchased. Although shares may be bought or sold on an exchange through any brokerage account, shares are not individually redeemable from the fund. Investors may acquire shares and tender them for redemption through the fund in large aggregations known as “creation units.” Please see the fund’s prospectus for more details.
Past Performance is not a guarantee of future results.
SPDR ETFs is the exchange traded funds (“ETF”) platform of State Street Global Advisors and is comprised of funds that have been authorised by Central Bank of Ireland as open-ended UCITS investment companies. The information contained in this communication is not a research recommendation or ‘investment research’ and is classified as a ‘Marketing Communication’ in accordance with the Markets in Financial Instruments Directive (2014/65/EU). This means that this marketing communication (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research.
SPDR ETF is the exchange traded funds ("ETF") platform of State Street Global Advisors and is comprised of funds that have been authorised by European regulatory authorities as open-ended UCITS investment companies. SPDR ETFs may not be available or suitable for you.
ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.
Changes in exchange rates may have an adverse effect on the value, price or income of an investment. Further, there is no guarantee an ETF will achieve its investment objective.
SHARES IN THE FUNDS OF THE SPDR® ETF SICAV, SSGA SPDR ETFS EUROPE I AND SSGA SPDR ETFS EUROPE II PLC MAY NOT BE AVAILABLE FOR OR SUITABLE FOR YOU. THE VIEWS EXPRESSED IN THIS SITE DO NOT CONSTITUTE INVESTMENT ADVICE. INDEPENDENT ADVICE SHOULD BE SOUGHT IN CASES OF DOUBT. NEITHER THE INFORMATION NOR ANY OPINION CONTAINED ON THIS SITE CONSTITUTES A SOLICITATION OR OFFER TO BUY OR SELL SHARES OF THE FUNDS OR ANY OTHER FINANCIAL INSTRUMENT.
Standard & Poor's®, S&P® and SPDR® are registered trademarks of Standard & Poor's Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation's financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index.
SPDR ETFs may be offered and sold only in those jurisdictions where authorised, in compliance with applicable regulations.
Information related to Mexico
This information does not constitute and is not intended to constitute marketing or an offer of securities and accordingly should not be construed as such. The Funds referenced herein have not been, and will not be, registered under the Mexican Securities Market Law (Ley del Mercado de Valores) and may not be publicly offered or sold in the United Mexican States. Disclosure documentation related to any of the aforementioned Funds may not be distributed publicly in Mexico and shares of the Funds may not be traded in Mexico.
You should obtain and read a prospectus and KIID relating to the SPDR ETFs prior to investing. Further information and the prospectus/KIID describing the characteristics, costs and risks of SPDR ETFs are available for residents of countries where SPDR ETFs are authorised for sale on the SPDRs website and from your local SSGA office.